Adaptive Biotechnologies Corporation — Quarterly Financial Statistics (NASDAQ:ADPT) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 27.07 M12.49 M28.48 M12.43 M7.13 M-2.06 M 45.99 M Cash from investing activities 5.29 M22.12 M25.57 M3.35 M17.28 M-8.25 M 37.95 M Cash from financing activities 40 K127 K5.45 M1.61 M1.68 M21.66 M 30.4 M Free cash flow 26.72 M12.41 M27.23 M11.78 M6.72 M-2.69 M 43.03 M

Notícias

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript

Adeptus Biotechnologies stock price target raised to $21 by TD Cowen

Thursday’s Insider Activity: Cavco Director Buys as Execs Sell Off

Adaptive Biotechnologies Corporation 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ADPT) 2026-02-06

Preço-alvo das ações da Adeptus Biotechnologies elevado para US$ 22 pela BTIG

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Slides da Adaptive Biotechnologies do 4º tri de 2025: crescimento de 55% na receita com expansão do negócio de DRM

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates

Adaptive Biotechnologies earnings on deck: Path to profitability in focus

CEO da Adaptive Biotechnologies vende US$ 2,3 milhões em ações